M, A., A, A., H, A., B, G. N., F, J., & M, F. (2026). Translational immunothrombosis in autoimmune Heparin-Induced thrombocytopenia: Targeting the FcγRIIa-Syk-BTK and complement pathways. Clinical and experimental medicine, 26(1), 151. https://doi.org/10.1007/s10238-026-02048-z
Chicago Style (17th ed.) CitationM, Ahmadinia, Askarzade A, Afsharara H, Gholizadeh Niari B, Jamali F, and Farasatinasab M. "Translational Immunothrombosis in Autoimmune Heparin-Induced Thrombocytopenia: Targeting the FcγRIIa-Syk-BTK and Complement Pathways." Clinical and Experimental Medicine 26, no. 1 (2026): 151. https://doi.org/10.1007/s10238-026-02048-z.
MLA (9th ed.) CitationM, Ahmadinia, et al. "Translational Immunothrombosis in Autoimmune Heparin-Induced Thrombocytopenia: Targeting the FcγRIIa-Syk-BTK and Complement Pathways." Clinical and Experimental Medicine, vol. 26, no. 1, 2026, p. 151, https://doi.org/10.1007/s10238-026-02048-z.